Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?

Introduction: Drug-induced liver injury (DILI) represents a serious medical challenge and a potentially fatal adverse event. Currently, DILI is a diagnosis of exclusion, and whilst the electronic evaluation of serious drug-induced hepatotoxicity (eDISH) have revolutionised the early assessment of DI...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Expert opinion on drug safety Ročník 15; číslo 5; s. 625 - 634
Hlavní autoři:	Clarke, Joanna I., Dear, James W., Antoine, Daniel J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Taylor & Francis 03.05.2016
Témata:	Acetaminophen Acetaminophen - adverse effects Biomarkers - metabolism Chemical and Drug Induced Liver Injury - diagnosis Chemical and Drug Induced Liver Injury - etiology Chemical and Drug Induced Liver Injury - therapy DILI Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - physiopathology Humans idiosyncratic Prognosis qualification Sensitivity and Specificity qualification DILI Acetaminophen idiosyncratic
ISSN:	1474-0338, 1744-764X, 1744-764X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!